Close

Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs

Go back to Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs

Novavax (NVAX) to Resume Trading at 4:35 PM ET

July 24, 2017 4:15 PM EDT

Novavax (NASDAQ: NVAX) to Resume Trading at 4:35 PM ET

... More